InvestorsHub Logo
Followers 5
Posts 809
Boards Moderated 0
Alias Born 08/30/2017

Re: PStockPickz post# 33

Wednesday, 09/05/2018 1:32:24 PM

Wednesday, September 05, 2018 1:32:24 PM

Post# of 5639
The company expecting to get an approval using the data they've already collected from the trial studies. Company stated they have sufficient data for a FDA approval upon resubmitting the data. I believe the FDA will approve their resubmitting paperwork of the clinical trial study. The study missed the end cap by a micro fracture of 2 of 247. I will hold my shares until the approval.

The guideline change while Histogenics Corp were conducting their clinical trial studies. It was stated in the conference today.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News